Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 6/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.40 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KIT | P10721 | 1/20 | 0.36 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CIT | O14578 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097227 | 0.90 | PIK3CD (0.43) | PIK3CDPIK3CAKDRNAMPTLMNA | |
| SCHEMBL8099845 | 0.89 | KDR (0.41) | PIK3CDPIK3CAKDRNAMPTLMNA | |
| SCHEMBL8096016 | 0.88 | PIK3CD (0.43) | PIK3CDPIK3CAKDRNAMPT | |
| SCHEMBL8104038 | 0.88 | CA12 (0.41) | PIK3CDPIK3CAEPHX2 | |
| SCHEMBL8091995 | 0.86 | PIK3CD (0.41) | PIK3CDPIK3CAKDR | |
| SCHEMBL8105807 | 0.86 | PIK3CD (0.42) | PIK3CDPIK3CAKDRNAMPTLMNA | |
| SCHEMBL8081823 | 0.86 | PIK3CD (0.42) | PIK3CDPIK3CAKDRNAMPTLMNA | |
| SCHEMBL8099812 | 0.85 | NAMPT (0.44) | PIK3CDPIK3CAKDRNAMPTCIT | |
| SCHEMBL8091758 | 0.85 | PIK3CD (0.43) | PIK3CDPIK3CAKDRNAMPTEPHX2 | |
| SCHEMBL8091998 | 0.85 | KIF11 (0.40) | PIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |